Steven D. Miller
Steven D. Miller's purchase track record
Steven D. Miller has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/30/2021 | BHC | $1.45M | -1.7% | -59.2% | -9.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
BHC appoints interim CEO and looks to raise FY26 EBITDA guidance. Bausch Health announced that its chairman, Thomas J. Appio, will serve as interim chief executive effective immediately. The company and its parent also said they expect to raise the adjusted EBITDA guidance for fiscal year 2026, not including the recently acquired IPR&D business. A separate notice confirms that the firm will release its third‑quarter 2026 results on October 28. Analysts at Zacks included Bausch Health in a recent coverage roundup, highlighting the stock among other health‑care names.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Dana Gets EU Approval For Eaton Mobility Deal. Dana Incorporated has received European Commission approval to acquire Eaton's mobility operations. This regulatory green light is a key step in finalizing the transaction, which aims to expand Dana's presence in the European market. The approval removes a major uncertainty that had been weighing on the deal's timeline.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Conduent Sets Investor Day for September 30, 2026. Conduent announced it will host an Investor Day on September 30, 2026. This event is expected to provide updates on the company's strategy and performance. The stock is currently trading near its 52-week low, making this upcoming presentation a key moment for stakeholders to assess the company's outlook.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
XRX Faces Pressure from Rising Junk Bond Yields Amid Growth Plans. XRX is in a pressure zone as junk bond yields climb above 15%. The stock has risen 11.5% over the past three months, showing resilience. At the PRINTING United Expo 2026, Xerox announced a major expansion of its production print portfolio, signaling growth plans.
Transaction History
| JBLU | ▲ Buy | Option Exercise | 22,094 | — | 3/10/2026 | View on chart |
| BHC | ▲ Buy | Grant | 54,347 | $0 | 5/16/2025 | View on chart |
| BHC | ▲ Buy | Grant | 35,360 | $0 | 5/17/2024 | View on chart |
| DAN | ▲ Buy | Option Exercise | 2,886 | $0 | 2/15/2024 | View on chart |
| CNDT | ▲ Buy | Grant | 53,522 | $190K | 1/15/2024 | View on chart |
| XRX | ▲ Buy | Grant | 22,561 | $0 | 5/25/2023 | View on chart |
| BHC | ▲ Buy | Grant | 29,205 | $0 | 5/19/2023 | View on chart |
| CNDT | ▲ Buy | Grant | 40,861 | $190K | 1/15/2023 | View on chart |
| BHC | ▲ Buy | Grant | 4,589 | $29K | 12/30/2022 | View on chart |
| BHC | ▲ Buy | Grant | 4,444 | $31K | 9/30/2022 | View on chart |
| BHC | ▲ Buy | Grant | 3,663 | $31K | 6/30/2022 | View on chart |
| BHC | ▲ Buy | Grant | 34,387 | $0 | 6/24/2022 | View on chart |
| XRX | ▲ Buy | Grant | 17,951 | $0 | 5/19/2022 | View on chart |
| BHC | ▲ Buy | Grant | 1,340 | $31K | 3/31/2022 | View on chart |
| XRX | ▲ Buy | Grant | 222 | $0 | 2/17/2022 | View on chart |
| CNDT | ▲ Buy | Grant | 33,629 | $190K | 1/15/2022 | View on chart |
| BHC | ▲ Buy | Grant | 1,109 | $31K | 12/31/2021 | View on chart |
| BHC | ▲ Buy | Open Market | 50,000 | $1.2M | 11/30/2021 | View on chart |
| BHC | ▲ Buy | Open Market | 10,000 | $242K | 11/30/2021 | View on chart |
| BHC | ▲ Buy | Grant | 1,099 | $31K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
JetBlue Loses LaGuardia Slots, Susquehanna Cuts Price Target to $4
JetBlue lost its LaGuardia Airport slots to American Airlines, a change that could significantly impact its future financial performance. Following this development, Susquehanna maintained a Neutral rating on the stock but lowered its price target to $4. The news aligns with a broader sector trend where airline stocks are facing pressure from short sellers and rising oil costs.
JetBlue Loses LaGuardia Slots, Susquehanna Cuts Price Target to $4. JetBlue lost its LaGuardia Airport slots to American Airlines, a change that could significantly impact its future financial performance. Following this development, Susquehanna maintained a Neutral rating on the stock but lowered its price target to $4. The news aligns with a broader sector trend where airline stocks are facing pressure from short sellers and rising oil costs.